GSBS Student Publications

UMMS Affiliation

Graduate School of Biomedical Sciences; Department of Molecular Genetics and Microbiology; Department of Medicine, Division of Diabetes

Date

9-12-2008

Document Type

Article

Medical Subject Headings

Animals; Antigens, CD19; B-Lymphocytes; Cell Nucleus; Cell Separation; Flow Cytometry; Humans; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Pneumococcal Vaccines; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Signal Transduction

Disciplines

Life Sciences | Medicine and Health Sciences

Abstract

The production of fully immunologically competent humanized mice engrafted with peripheral lymphocyte populations provides a model for in vivo testing of new vaccines, the durability of immunological memory and cancer therapies. This approach is limited, however, by the failure to efficiently engraft human B lymphocytes in immunodeficient mice. We hypothesized that this deficiency was due to the failure of the murine microenvironment to support human B cell survival. We report that while the human B lymphocyte survival factor, B lymphocyte stimulator (BLyS/BAFF) enhances the survival of human B cells ex vivo, murine BLyS has no such protective effect. Although human B cells bound both human and murine BLyS, nuclear accumulation of NF-kappaB p52, an indication of the induction of a protective anti-apoptotic response, following stimulation with human BLyS was more robust than that induced with murine BLyS suggesting a fundamental disparity in BLyS receptor signaling. Efficient engraftment of both human B and T lymphocytes in NOD rag1(-/-) Prf1(-/-) immunodeficient mice treated with recombinant human BLyS is observed after adoptive transfer of human PBL relative to PBS treated controls. Human BLyS treated recipients had on average 40-fold higher levels of serum Ig than controls and mounted a de novo antibody response to the thymus-independent antigens in pneumovax vaccine. The data indicate that production of fully immunologically competent humanized mice from PBL can be markedly facilitated by providing human BLyS.

Rights and Permissions

Citation: PLoS ONE. 2008 Sep 11;3(9):e3192. Link to article on publisher's site

DOI of Published Version

10.1371/journal.pone.0003192

Related Resources

Link to Article in PubMed

Journal Title

PLoS ONE

PubMed ID

18784835

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.